BIA Update | 15 August 2022

With the August lull and many people taking well-earned breaks, at BIA we are forging ahead with planning new events and new directions for 2023. As BIA membership continues to grow and thrive we face the challenge of continuing to connect and engage effectively with ever larger numbers of member companies and their employees, and we’re looking to address this with additional capabilities and exciting new initiatives.

We also hear loud and clear your challenges as scaling biotech and techbio companies in finding talent, space and financing. BIA has a strong heritage of campaigning for the right financial support for biotech in the UK, and this will continue to grow. You will also start to see a burgeoning skills and talent agenda at BIA, addressing skills gaps and diversity, equity and inclusion (DEI) in the sector, encouraging life sciences entrepreneurship and developing sector leadership.

As technology advances continue to accelerate, you’ll see our TechBio, EngBio and Genomics work continue to grow – with a flagship event TechBio UK in October, and more showcasing of the incredible companies coming through in these areas.

Whilst we develop new thinking, we will of course continue the BIA’s sterling work across the broader sphere of innovative life sciences, maintaining our proud position as the most impactful association for innovative life sciences in the UK.

Not yet a member, but would like to find out more? Now is the time to contact our team.

If you are already a member, please note that the BIA Board is currently open for nominations - submit yours before 9 September! 

Jane Wall


Jane Wall

Director, Business Development and Membership Services
BioIndustry Association (BIA)


More news and updates

The Growth Plan: the new Chancellor’s mini-Budget and what it means for life sciences

Making his first statement as Chancellor of the Exchequer today, Kwasi Kwarteng said the UK enjoys an “unbound entrepreneurial culture” and “immense global presence in sectors like… life sciences”, but that in many areas of the economy, he said, tax and regulation is holding back growth. Read more about key announcements for life sciences in the new Plan for Growth and three priority areas for expanding the supply side of the economy.

Mini-Budget positions UK life sciences to drive new government's economic growth agenda

The Chancellor of the Exchequer today announced at the mini-Budget the Long-Term Investment for Technology & Science (LIFTS) competition. This will provide up to £500 million to support new funds designed to catalyse investment from pensions schemes and other investors into the UK’s pioneering science and technology businesses, this is a direct result of the life science scale up agenda that the BIA has championed and worked closely with government on.

CEO Update | 20 September 2022

Yesterday the United Kingdom paid its final respects and laid to rest Queen Elizabeth II in an incredible state funeral in central London, a ceremony of which we haven’t seen in a generation and was marked and watched across the entire world. As the chapter closes on the 70 years of the Elizabethan age, I have reflected on the innovations and changes we have seen in the sector over that period and look forward to the advances the sector will make under our new King.

CEO Update | 12 September 2022

All of us at the BioIndustry Association (BIA) have been shocked and saddened by the death of the Queen. I shared a reflection on her life from a life science industry perspective on Friday. We are also posting official guidance from the UK Government on what to do during this extraordinary period for BIA members. Next Monday will see the State Funeral and a UK Bank Holiday – BIA will be closed on the day and next week’s Newscast will be on Tuesday. For the rest of this week, we continue to work as normal.

More within